Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.

[Q]: Paragraph: But COVID-19 is shaking her views. The woman who would identify herself only as Stephanie, citing a fear of reprisals from committed anti-vaxxers, says she is now 50:50 on taking a vaccine should one be discovered for the respiratory disease caused by the new coronavirus. “I’ve definitely thought about it,” she told Reuters by phone from the United States, also expressing frustration at what she considers the anti-vax community’s downplaying of the pandemic’s seriousness. “We’re all being affected by this virus, schools closing, young people in hospital, and they still say it’s a hoax.”  As the world’s scientists and pharmaceutical companies seek a cure for the coronavirus, other anti-vaxxers are gearing up for a fight against any potential new vaccine. “Refuse, demonstrate,” said a Briton on Facebook in response to a post asking people how they would react if a vaccine was made mandatory. But some virologists say the quest for a vaccine is so widely supported that resistance will be eroded. The latest national surveys by pollster ORB International for the Vaccine Confidence Project (VCP), which monitors attitudes to immunisation, appear to support this idea. In France, where a 2018 poll showed one in three people did not view vaccines as safe, just 18% would refuse a coronavirus vaccine now, according to the VCP poll of around 1,000 people on March 18, a day after France locked down. In Australia, the VCP’s figure was also 7%, while Britain, where about 2,000 people were polled, and Austria registered 5% opposition in polls there a week later. “If a vaccine were made available tomorrow, everyone would jump to get it,” said Laurent-Henri Vignaud, who co-authored a history of France’s anti-vax movement. That view was challenged by Mary Holland, vice-chair of American non-profit group Children’s Health Defense, which is critical of vaccination in the United States. “I don’t think this virus fundamentally changes people’s deeply held concerns about vaccines,” she told Reuters. Although the term “anti-vax” is sometimes associated with conspiracy theories, many people are simply concerned about side-effects or industry ethics. Globally, one person in five does not view vaccines as safe or is unsure, according to a 2018 survey by the Wellcome Trust health fund. reut.rs/2JTb27q  In China, where the COVID-19 disease caused by the novel coronavirus originated, surveys by VCP researchers show safety is an important cause of concern. Several scandals eroded trust, including in 2018 when a unit of China’s vaccine maker Changsheng Bio-technology Co Ltd was heavily fined for falsifying data for a rabies vaccine. The company said it was “deeply sorry” for the incident. Online discussions tracked by Reuters - including closed Facebook pages with more than 200,000 members, Twitter feeds such as the Children’s Health Defense and YouTube videos totalling over 700,000 views - showed considerable mistrust that a rushed vaccine would be improperly tested. VCP director Heidi Larson said that was also the main reason for concern around the vaccine against the H1N1 swine flu pandemic in 2009. A quickly produced swine flu vaccine in 1976 led to about one in 100,000 people developing Guillain-Barre syndrome, a paralyzing immune-system disorder, according to the Center for Disease Control and Prevention (CDC). Some 115 coronavirus vaccine candidates are being developed by institutes and drugmakers, according to the Coalition for Epidemic Preparedness Innovation, a global alliance financing and coordinating the development of vaccines. “I will not be injected with anything, especially a fast-tracked vaccine,” added American Vicki Barneck, 67, who believes a strong immune system is enough to combat the disease. Holland, of the Children’s Health Defense, said: “Some react fine to vaccines, others are paralysed or killed.”   However, a 2015 paper by CDC epidemiologists said “multiple studies and scientific reviews have found no association between vaccination and deaths except in rare cases.”  The VCP is running an 18-month study tracking conversation online about the coronavirus and conducting global polls to measure attitudes towards social distancing, isolation, hand-washing and anticipating a vaccine. From analysing more than 3 million posts a day between January and mid-March 2020, director Dr Heidi Larson said the vast majority were eager for a treatment, fast. “People are hungry for a vaccine,” she said. In Italy, which has been hit badly by COVID-19, the anti-vax movement has “virtually disappeared” in the discussion on the coronavirus, according to virologist Dr Roberto Burioni. For a coronavirus vaccine to be effective, wide uptake and annual vaccination is likely to be required, said George Kassianos, immunisation lead at the Royal College of General Practitioners in London. There is also the question of how to distribute fast enough to people lining up for the vaccine. “Essential workers will be the priority. Police officers, hospital workers, cleaners. Then at-risk groups,” said Douglas L. Hatch, a physician specialised in pandemic preparedness working on the COVID-19 response in San Francisco. “By the time you get to the anti-vaxxers, they’ll have trouble getting it even if they wanted to.”  (Corrects French poll data in eighth paragraph) Claim: Could the new coronavirus weaken 'anti-vaxxers'?.
[A]: An American mother-of-three is a long-time member of “anti-vaxxer” groups online: a small but vocal global community that believes vaccines are a dangerous con and refuse to immunize themselves or their children.


[Q]: Paragraph: No mention of the cost of treatment. This is important if the surgery is not a permanent fix for acute sinusitis. Repeated operations and continued medications need to be compared to cost for traditional surgery. No quantitative estimate of the benefits of the new procedure. There was a study of 10 people that found “no safety concerns”, but readers should be told more about this very small group. What were the long term outcomes and did these patients eventually have to have further sinuplasty, more invasive surgery or continue to take medications to relieve sinusitits? The story mentions that a larger, randomized trial is underway to better understand the risks and benefits of sinuplasty compared to medication and traditional sinus surgery. Mentions that more information is needed and no one knows if balloon sinuplasty works as well as the more traditional surgical option for chronic sinusitis. Mentions that general anesthesia is still needed for balloon procedure and this comes with its own set of health risks. There isn’t much evidence for the story to report. The story did stress the importance of a randomized trial underway comparing medication, traditional sinus surgery and the newer balloon sinuplasty. Story describes this trial and the need for further evidence before this new procedure can be widely recommended. Mentions that this procedure should not have been FDA approved with so little quality evidence. No evidence of disease mongering. The story mentions that this procedure would be for chronic, not acute sinunitis and describes how these are different. Good balance of information on treatment options with input from otolaryngologists not affliated with the makers of the device who are able to provide perspective on the new procedure. They mention that further study is needed. There is a note that one of the physicans studying the new sinuplasty has no financial ties to Acclarent, maker of the balloon devices used in this type of sinuplasty. Mentions that this form of sinuplasty is not for everybody and that it may not prevent the need for more comprehensive surgery in which bone and tissue are removed. There is mention of other options including medication and the more traditional surgery, which is decribed as highly effective, but with a painful recovery and side effects such as scar tissue. Quantification of the incidence of this and other side effects of traditional surgery would be useful. The story is clear that the FDA approved the device but that it still needs to undergo further study via randomized controlled trials. Story mentions that this is a new procedure only offerred by 100 doctors. This story is a blananced presentation of sinuplasty and the information here does not appear to be from a press release. The are quotes from otolaryngologists not affliated with the makers of the device who are able to provide perspective on the new sinuplasty procedure. Claim: A balloon instead of a knife: Sinuplasty for ailing sinuses
[A]: This story provides a good balance of information on a new treatment option for chronic sinusitis, and there is corroboration with otolaryngologists not affiliated with the makers of the balloon device who are able to provide perspective on the procedure. The story clearly notes this procedure would be for chronic, not acute sinusitis and describes how these are different. The story explains that this form of sinuplasty is not for everybody, and that it may not prevent the need for more comprehensive surgery in which bone and inflamed tissue are removed to open the sinus passages. More information is needed on the safety and efficacy of balloon sinuplasty, and no one knows if this surgery works as well as traditional surgery for chronic sinusitis. The story mentions other options for treating chronic sinusitis, including medication and sinus surgery, which is described as highly effective, but with a painful recovery and side effects such as scar tissue. Quantification of the incidence of side effects with traditional surgery would be useful. While there is not much quantitative evidence available on the new procedure, the story stresses the importance of a randomized trial underway comparing medication, traditional sinus surgery and the newer balloon sinuplasty. There is adequate description of this trial and the need for further evidence before this new procedure can be widely recommended. There is a caveat that this procedure should not have been FDA approved with so little quality evidence: a study of 10 people that found “no safety concerns”, but readers should be told more about this very small group. What were the long term outcomes and did these patients eventually have to undergo further sinuplasty, more invasive surgery or continue to take medications to relieve their chronic sinusitis? The story explains that general anesthesia is still needed for the balloon procedure and this comes with its own set of health risks and additional costs. There is no mention of the cost of this newer procedure. This is important information if the surgery is not a permanent fix for chronic sinusitis. A cost comparison of the newer sinuplasty, which may require repeated operations, sinus medications and traditional surgery is needed.


[Q]: Paragraph: The state Marijuana Regulatory Agency’s emergency rules, which prohibit vitamin E acetate, apply to existing medical marijuana businesses and those in the process of being licensed to sell for recreational use as soon as Dec. 1. Regulators noted that U.S. health officials found the compound in the damaged lungs of 29 patients across the country who were sickened from vaping. “It is absolutely vital that patients and consumers know, with certainty, the ingredients in the products that they are using,” Lt. Gov. Garlin Gilchrist said in a written statement. “These rules require stringent testing and will continue to prioritize the health and safety of Michiganders.” Effective immediately, businesses cannot sell previously made marijuana vaping products unless they pass new testing. Processors making new products are barred from using inactive ingredients that have not been approved by the U.S. Food and Drug Administration. Regulators said they will inspect processing facilities twice a month to ensure compliance. Inactive ingredients added to marijuana products must be clearly listed on the label. Vitamin E acetate is used as an additive, most notably as a thickener in e-cigarette products that contain THC, which gives marijuana its high, according to the U.S. Centers for Disease Control and Prevention. Though vitamin E is safe as a pill or to use on the skin, inhaling oily droplets of it can be harmful. Fifty-five vaping-related lung injuries have been identified in Michigan, including a 17-year-old boy who needed a life-saving double lung transplant. This is the second time since September that Gov. Gretchen Whitmer’s administration has taken emergency steps to limit vaping. Her ban on the sale of flavored e-cigarettes has been blocked by a state judge and is being appealed. An industry group backed the latest rules on Friday. “We’re fully supportive of the governor’s decision,” said Robin Schneider, executive director of the Michigan Cannabis Industry Association. “Our member’s No. 1 priority is providing safe, tested medicine to medical marijuana patients across the state. We think this will contribute significantly towards that goal.” ___ Follow David Eggert on Twitter: https://twitter.com/DavidEggert00 Claim: Michigan halts sale of marijuana e-cigs unless re-tested.
[A]:
Michigan on Friday halted the sale of marijuana vaping products until they are tested for a compound that has been identified as a culprit in e-cigarette-related lung illnesses.